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The pancreatic beta cell functions as a key regulator of blood glucose levels
by integrating a variety of signals in response to changing metabolic demands.
Variations in beta cell identity that translate into functionally different subpopulations
represent an interesting mechanism to allow beta cells to efficiently respond to diverse
physiological and pathophysiological conditions. Recently, there is emerging evidence
that morphological and functional differences between beta cells exist. Furthermore, the
ability of novel single cell technologies to characterize the molecular identity of individual
beta cells has created a new era in the beta cell field. These studies are providing
important novel information about the origin of beta cell heterogeneity, the type and
proportions of the different beta cell subpopulations, as well as their intrinsic properties.
Furthermore, characterization of different beta cell subpopulations that could variably
offer protection from or drive progression of diabetes has important clinical implications
in diabetes prevention, beta cell regeneration and stem cell treatments. In this review, we
will assess the evidence that supports the existence of heterogeneous populations of
beta cells and the factors that could influence their formation. We will also address novel
studies using islet single cell analysis that have provided important information toward
understanding beta cell heterogeneity and discuss the caveats that may be associated
with these new technologies.
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INTRODUCTION
The pancreatic beta cell is an essential endocrine cell type whose identity has been traditionally
defined by its function: producing, storing and secreting insulin. However, this definition over-
simplifies a more complex identity that is finely tuned to efficiently regulate blood glucose levels,
while maintaining the ability to adapt to a wide range of stimuli and physiological challenges.
Recent studies have spurred an intense debate about whether beta cells represent a single
homogeneous population or consist of subpopulations with functional and molecular variations
to facilitate specialized tasks and responses to changes in the physiological environment. If beta
cell heterogeneity exists, it will be important to determine whether it is a means by which beta
cells functionally adapt during normal and pathological conditions and, in particular to the
development and progression of diabetes. This could have profound implications for our ability
to understand and treat the disease.
In this review, we will discuss the evidence supporting the existence of beta cell heterogeneity,
the mechanisms influencing its development, and its functional relevance. We will discuss recent
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studies that shed light on the molecular aspects of beta cell
heterogeneity and exciting areas of research that have yet to be
applied to the beta cell field.
EXAMPLES OF CELL HETEROGENEITY
To understand heterogeneity, we need to first consider where
it originates, and the advantage of its existence. It is well
established that most organisms constantly evolve to successfully
adapt to their environment; leaving only the fittest populations
with the ability to survive (Darwin, 1859). In order to adapt,
cell populations have to find the best strategy with regard to
the division of essential functions. Theoretical research on the
concept of division of labor within biological systems suggests
that populations can be composed of either generalists or
specialists; generalists perform all tasks and specialists perform
particular ones. Interestingly, it is the populations that balance
and divide their tasks into specialized subgroups that seem to be
the fittest (Wahl, 2002).
Evidence to support the concept of specialization is present at
all levels of nature, with populations dividing into functionally
different groups in order to have a survival advantage, to respond
timely and efficiently to challenges in the environment, and to
ultimately accomplish the purpose of the population as a whole.
For example, heterogeneity in the division of labor is exemplified
in the partitioning of incompatible yet complementing functions
of cyanobacteria (Flores and Herrero, 2010). Adaptation to
environmental challenges can also be observed in the ability
of bacterial populations to acquire resistance to antibiotics, in
the capability of yeast populations to adapt to highly toxic
environments, and in the differential rate of infection in cells after
viral exposure (Balaban et al., 2004; Bishop et al., 2007; Snijder
et al., 2009). Effective and prompt response to challenges can
also be observed in the development of subgroups of immune
or neural cells destined to respond to insults such as injury or
hypoxia (Miklos and Kovacs, 2003; Llorens-Bobadilla et al., 2015;
Silvestre-Roig et al., 2016). Heterogeneity has therefore evolved to
provide cells with the most efficient way to perform its functions.
For this reason, it is essential to consider the ultimate duties
a cell has to perform, how these functions are most efficiently
carried out and what information the architectural composition
and molecular signatures can provide.
BETA CELL HETEROGENEITY
Beta cell heterogeneity has recently received increasing attention,
and studies are emerging that challenge our understanding of
beta cell identity. As we learn more about the potential for
variation in the beta cell population, it is important to consider
the developmental origin of beta cells, their highly interactive
nature, and the variety of input signals they receive. These, among
other factors can lead to the development of different types of
heterogeneity.
Cell to cell variations exist in several different dimensions
ranging from observable physical features to biochemical and
molecular fluctuations. While these differences are becoming
easier to identify, it is important to determine whether
biologically relevant functions are associated with the observed
changes in identity. In this regard, the amount of evidence that
supports the existence of significant and relevant variation in beta
cells has grown stronger in the last decade. Furthermore, several
studies have provided clues as to the origin of cellular variations,
which are possibly established from the beginning of pancreas
and/or endocrine cell differentiation.
BETA CELL HETEROGENEITY DURING
DEVELOPMENT
In rodents and humans, regional differences in the pancreas
exist during the earliest stages of fetal development, with the
pancreas arising from two epithelial buds that form from
non-contiguous regions of the distal foregut endoderm in
response to distinct signaling events (Jennings et al., 2015). As
pancreas development progresses, the pancreatic buds fuse to
form one organ; however, the ratio of pancreatic endocrine
populations display clear regional differences depending on their
development origin: the dorsal pancreas gives rise to islets with
a higher proportion of somatostatin and glucagon expressing
cells, while the ventral pancreas contains islets rich in pancreatic
polypeptide cells (Trimble and Renold, 1981; Trimble et al., 1982;
Brereton et al., 2015; Jansson et al., 2016). It remains to be
determined whether the regional origin of the beta cells from
the dorsal versus ventral pancreas also translates into differences
of identity in the adult beta cell population. In addition, during
human pancreagenesis, at least two distinct populations of
endocrine cells are evident: freely dispersed cells and cells that
group together to form the islets of Langerhans. To date, the
differences or purpose of the freely localized beta cells remains
unknown, likely because these cells are lost during standard
islet isolation procedures. Nevertheless, both populations contain
individual cells that express multiple combinations of the
endocrine hormones (polyhormonal) in the early stages; but
as development progresses, the beta cells acquire their insulin-
expressing monohormonal identity and become functionally
mature. As the polyhormonal cells resolve into single insulin-
producing cells, it is unknown whether all or subpopulations
of beta cells preferentially arise from a particular polyhormonal
population. It remains possible that beta cells originate from
different polyhormonal combinations, which could result in
molecularly and/or functionally distinct beta cell subpopulations.
Interestingly, heterogeneity also exists during the maturation
event with beta cells located within the core of the islet maturing
first, followed by the maturation of cells within the outer part of
the islet (Bocian-Sobkowska et al., 1999).
Although fewer polyhormonal cells are present in the
developing rodent pancreas, genetic disruption of transcription
factor function provides additional evidence for the existence of
beta cell heterogeneity during gestation. For example, depletion
of Nkx6.1 in endocrine precursor cells results in decreased
numbers of insulin+ cells (∼16% compared to 55% in the
control mice) and an allocation of the endocrine precursor
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population into other endocrine identities (Schaffer et al., 2013).
Similarly, global deletion of Mafb or Mnx1 renders a partial
reduction in beta cell numbers; 50% in the case of Mafb and
approximately 65% in the case of Mnx1 (Harrison et al., 1999;
Li et al., 1999; Artner et al., 2007). If we assume that all beta
cells have a homogeneous origin that is specified by the same
transcriptional pathways, we would expect that disruption of
these regulatory pathways would result in ablation of the entire
beta cell population. Instead, we observe differential beta cell
responses to alterations in certain transcriptional pathways that
could indicate the formation of subpopulations of beta cells from
the earliest developmental stages.
MORPHOLOGICAL HETEROGENEITY
Indications of heterogeneity in adult beta cells were initially based
on morphological features, which included noticeable differences
in nuclear size (Hellerstrom et al., 1960). Subsequently, with
the application of improved electron microscopy techniques,
differences in organelle size and secretory granule content were
documented (Stefan et al., 1987; Kiekens et al., 1992; Ling
et al., 2006; Katsuta et al., 2012). Furthermore, it appeared that
glucose stimulation resulted in functional changes that were
initiated in the islet core: Beta cells within the core of the
islet de-granulated rapidly and presented with enlarged rough
endoplasmic reticulum and Golgi apparatus, while peripheral
beta cells only began to de-granulate after sustained glucose
stimulation (Stefan et al., 1987). Furthermore, differences in
insulin granularity did not only pertain to their location within
the islet but also to the identity of their neighboring cells, as
beta cells coupled to delta cells showed increased insulin granule
content (Pipeleers, 1987).
Evidence of morphological heterogeneity extended beyond
the internal features of the beta cell, and into the molecular
mechanisms responsible for interacting with other islet cells. Gap
junctions, which are important for beta cell coupling, were also
found to have heterogeneous expression patterns. Meda et al.
(1980) observed twice as many gap junctions in the periphery
of the islet under basal conditions; nucleotide transfer and
dye coupling experiments later confirmed the heterogeneous
nature of coupling mechanisms between beta cells (Meda et al.,
1981, 1983). Collectively, differences in morphological features
have provided strong evidence for the existence of beta cell
heterogeneity at the molecular and functional level.
FUNCTIONAL HETEROGENEITY
The existence of functional variations within the beta cell
population would offer advantages for their ability to respond
robustly to different physiological conditions, especially given
the consequences of having insufficient or excess insulin in the
body. It is likely that precise regulation of insulin secretion would
be difficult to accomplish if all beta cells were homogenous
in their glucose sensing and secretion capabilities as they
would all respond simultaneously with similar force to a given
stimulus, without an inherent ability to quickly adapt to changing
conditions. Alternatively, the existence of subpopulations of beta
cells with different thresholds for glucose would modulate the
response, and insulin secretion would be more tightly regulated.
Differences in the thresholds at which beta cells elicit an
insulin secretory response to glucose have been characterized by
several investigators. Giordano et al. (1991) observed that beta
cells have distinct insulin secretory patterns; with cells clustering
into two populations: responsive and unresponsive. Responsive
beta cells that secreted insulin during the first glucose challenge
also secreted insulin during subsequent stimulation assays.
Similarly, unresponsive beta cells remained non-responsive in
subsequent assays. Interestingly, in both responding and non-
responding populations, approximately 75% of the beta cells
displayed fixed responses; while 25% of beta cells fluctuated
between an unresponsive and responsive state (Giordano et al.,
1991). Several additional studies have also confirmed the
existence of beta cell populations that differed in their sensitivity
or capacity to respond to glucose (Soria et al., 1991; Kiekens et al.,
1992; Van Schravendijk et al., 1992; Ling et al., 1998).
Differential expression or activities of the factors and pathways
contributing to the insulin secretory response have also been
detected. Jetton and Magnuson (1992) found variation between
beta cells in the overall expression levels of glucokinase, a
rate-limiting enzyme that regulates one of earliest steps in
the glucose response. Furthermore, it has been demonstrated
that highly glucose responsive beta cells had a ∼60% increase
in glucokinase activity (Heimberg et al., 1993); suggesting
that glucose phosphorylation may be a determining factor
in influencing beta cell heterogeneity. Pioneering studies by
Dean and Matthews (1968) also showed that cells located near
the surface of the islet had larger membrane potentials and
there is early evidence showing that some but not all beta
cells are electrically coupled or synchronized (Meda et al.,
1984, 1991). However, assessment of specific electrophysiological
characteristics has not identified the relevant effectors of these
differences; the individual electrical membranes appear similar
despite their ability or inability to respond to glucose (Soria
et al., 1991). These data suggest that downstream effectors in the
glucose-stimulated insulin secretory process may be important
for the development of functional variations. One candidate
pathway could be related to the beta cells’ calcium responses,
which precede the last steps before insulin granule exocytosis,
and have been shown to vary between beta cells (Herchuelz et al.,
1991; Jonkers and Henquin, 2001; Benninger and Piston, 2014).
These functional studies demonstrate that there is heterogeneity
at several levels of the glucose response process; however, it is
not known how these differences are ultimately organized and or
associated with specific beta cell subpopulations.
A new model describing functional integration of beta cell
heterogeneity was recently described Johnston et al. (2016).
Through a novel set of experiments, insulin secretion responses
were found to be orchestrated by two populations of cells:
hub cells that function as pacemakers to dictate the insulin
secretion dynamics and follower cells that respond to hub cell
signaling cues. Interestingly, hub cells had increased glucokinase
levels and the influence of glucokinase was greatly decreased
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after gap junction inhibition, consistent with previous studies
showing differential expression of both glucokinase and gap
junction coupling in islet beta cells (Meda et al., 1980, 1981, 1983;
Jetton and Magnuson, 1992; Heimberg et al., 1993; Benninger
and Piston, 2014). Interestingly, hub cells were more sensitive
to diabetic-like insults; likely due to their high metabolic rate
and immature phenotype. The driving forces behind these
populations remain to be analyzed. Furthermore, it will be
important to determine if other functional beta cell groups
exist and how they interact with each other and contribute to
development and progression of disease.
Equally important to having mechanisms that allow a graded
response to different glucose stimuli, would be the ability
to impart subpopulations with specialized functions, such as
proliferative capacity or responsiveness to non-glucose stimuli,
such that the beta cell population would more efficiently respond
to the many environmental challenges it routinely encounters.
Several lines of evidence have recently emerged to suggest the
existence beta cells with specialized capacities. Soria et al. (1991)
demonstrated that beta cells that were otherwise unresponsive
to glucose could in fact secrete insulin when presented with
an appropriate stimulus, such as tolbutamide. Similarly, glucose
non-responsive beta cells were shown to exert an insulin secretion
response when stimulated with glucagon (Giordano et al.,
1991) or glucagon-like peptide 1 (Holz et al., 1993; Gromada
et al., 1995). More recently, Flattop (Fltp) was identified as a
molecular marker whose expression differentiates populations
of beta cells based on their mature or proliferative capacity
(Bader et al., 2016). Collectively, these findings suggest there are
different layers of functional complexity that exist within the
beta cell population that could endow beta cells with differential
capabilities to respond to a diverse set of stimuli and challenges.
MOLECULAR HETEROGENEITY
Presently, novel technological advances are creating a new era in
the beta cell field, allowing us to identify the molecular fingerprint
of individual cells. To begin to lay the foundation for studying
beta cells at the molecular level, two approaches have been
undertaken: an unbiased analysis of gene expression through
single cell RNA sequencing, and the separation of beta cells into
groups that differ in their protein expression. Although there are
caveats associated with single cell RNA sequencing approaches
(Xin et al., 2016a), several studies have provided important new
insights into beta cell biology (Bader et al., 2016; Baron et al.,
2016; Dorrell et al., 2016; Li et al., 2016; Muraro et al., 2016;
Segerstolpe et al., 2016; Wang et al., 2016; Xin et al., 2016b).
The separation of cells based on protein expression has also
resulted in the discovery of several molecular markers ranging
from cell-surface proteins to intracellular molecules involved
in metabolism that are differentially expressed in a beta cell
subpopulation or denote a particular metabolic state (Figure 1)
(Pipeleers, 1987; Jetton and Magnuson, 1992; Kiekens et al., 1992;
Giordano et al., 1993; Heimberg et al., 1993; Jorns et al., 1999;
Guz et al., 2001; Johnson et al., 2006; Bosco et al., 2007; Hermann
et al., 2007; Saisho et al., 2008; Wang et al., 2008, 2016; Karaca
et al., 2009; Szabat et al., 2009; Smukler et al., 2011; Katsuta et al.,
2012; Bader et al., 2016; Beamish et al., 2016; Dorrell et al., 2016).
While the identification of specific molecular markers offers
a feasible method to characterize distinct beta cell populations,
gene expression analyses of single human beta cells have reported
contrasting results. Three research groups have described
heterogeneity in the beta cell population with particular gene
signatures driving such differences (Baron et al., 2016; Muraro
et al., 2016; Segerstolpe et al., 2016). However, Xin et al.
(2016b) were not able to detect such diverse cell types. Several
reasons could account for these discrepancies. In particular, the
source and condition of the islets could impact their phenotypes
(Figure 2). Furthermore, there are clear limitations associated
with existing technologies, especially with regards to sensitivity
of detection of low abundance transcripts, and the fact that the
manipulations required for analysis can easily influence beta cell
states. In addition, most of the studies to date have been restricted
by the limited access to sufficient numbers of human samples.
Ultimately, characterization of larger sample sizes from well
controlled populations will allow us to more precisely define the
number of discrete beta cell populations based on gene expression
and the degree to which the different populations overlap.
Studies of human islets based on the expression of the
cell surface antigenic markers CD9 and ST8SA1 have also
successfully identified at least four distinct populations of beta
cells (Dorrell et al., 2016). However, a study that categorized
beta cells based on their expression of factors involved in
proliferation, signaling pathways, maturation, and previously
identified heterogeneity factors, suggested there were three
different beta cell subpopulations (Wang et al., 2016). Again,
these differences could be due to the source and/or experimental
conditions of the islet cells analyzed (Figure 2), in addition to
the selection criteria, which may enrich for abundant and rare
populations differently. Notably, however, these studies were able
to correlate potential functional distinctions between the different
beta cell populations, including variations in the expression
of SLC2A2, an important glucose transporter, and restricted
expression of several proliferative factors (PDGFRA, pERK1/2,
pSTAT3 and pSTAT5) (Dorrell et al., 2016; Wang et al., 2016).
It is interesting that these studies identified many genes without
prior association with beta cell biology, several of which appear to
be involved in insulin secretion regulation (Dorrell et al., 2016).
Although all of these studies have revealed significant novel
information about individual beta cells, it has proven challenging
to identify clear cut evidence of the pathways or factors that
regulate the molecular aspects behind the variations in beta
cell identity and functions. Furthermore, despite the numerous
documented gene and protein expression differences, it is
intriguing that many of the factors known to regulate diverse
beta cell functions are robustly and homogeneously expressed
in all beta cells. This would imply that many of the differences
between beta cell populations may also involve other layers
of molecular complexities, including epigenetic modifications,
relative differences in protein levels and/or changes in post-
translational modifications. Therefore, it is likely that to fully
understand the phenomenon of beta cell heterogeneity at the
molecular level, it will be important to characterize the full
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FIGURE 1 | Beta cell heterogeneity markers. Schematic indicating the primary molecules that were used to separate islet beta cell subpopulations. Each factor
is categorized based on its surface localization or function. The distinct beta cell subpopulations are schematized as different colored dots and the main phenotypic
characteristics or functions associated with these beta cell subpopulations are indicated. This schematic summarizes the concepts and respective references that
were discussed in the text.
range of biochemical and molecular differences that make each
population unique.
CONTEXT DEPENDENT FACTORS
INFLUENCE HETEROGENEITY
As the existence of beta cell heterogeneity becomes more
tangible, it is important to consider what the main drivers of
beta cell heterogeneity are. Although heterogeneity could be
an intrinsic “context independent” property of the cell based
on age or disease states, it is also possible that it could stem
from adaption to the environment, including changes in physical
interactions and signals received from neighboring cells and
tissues (Figure 2). Furthermore, alterations in the ratios of
different beta cell populations could arise from mechanisms
regulating the relative size of the individual populations or
interconversion between the different populations. At the organ
level, significant differences in the proportion of endocrine cells
and pro-hormone processing have been found between the
ventral and dorsal pancreas in rodents and humans (Trimble and
Renold, 1981; Stefan et al., 1982; Trimble et al., 1982; Rahier
et al., 1983; Lee et al., 2010; Wang et al., 2013; Jansson et al.,
2016). Proliferation differences have been observed between the
duodenal, gastric and splenic region; with the later presenting
the most proliferation (Ellenbroek et al., 2013). Differences
in insulin degranulation are more evident in splenic regions
compared to the duodenum (Stefan et al., 1987); concomitantly,
higher rates of insulin biosynthesis and secretion follow the
same pattern (Trimble and Renold, 1981; Trimble et al.,
1982).
At the islet level, the location of beta cells could also be
important for their differential responsiveness. Investigators
have shown that not all beta cells are in close contact with
neuronal axons (Rodriguez-Diaz et al., 2011), and differences
exist in the proximity and access to capillaries, which provide
important factors, such as oxygen and nutrients (Bonner-
Weir, 1988; Cabrera et al., 2006). Often, such differences
depend on islet size and location within the islet (Ballian
and Brunicardi, 2007). There are also important influences
exerted by the other pancreatic endocrine hormones that
affect the beta cell insulin secretion response. Contact between
beta and alpha cells increases the insulin secretion output
(Pipeleers et al., 1982; Wojtusciszyn et al., 2008); while
somatostatin negatively influences insulin secretion (Efendic
and Luft, 1975; van der Meulen et al., 2015). Collectively,
it is evident that beta cell heterogeneity is likely to exist,
with differences that extend from the individual cell level
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FIGURE 2 | Potential factors influencing beta cell heterogeneity. The blue squares indicate the different conditions that have the potential to influence the
development of beta cell heterogeneity in mice and human, respectively. This schematic summarizes the concepts that are discussed and referenced in the text. The
green square contains the different contextual conditions that may contribute to heterogeneity. Experimental factors with the capacity to dilute or obscure the
discovery of beta cell heterogeneity are shown in the red square.
to regional differences at the organ level. Determining the
origins and advantages of these variations in beta cell identity,
as well as how they are shaped must become a main
priority.
BETA CELL HETEROGENEITY AND
EFFECTS ON DISEASE PROGRESSION
AND THERAPIES
Recognizing that beta cell heterogeneity exists is interesting;
however, understanding how beta cell heterogeneity can protect
or drive the development of diabetes; as well as how we can
apply such information to design disease therapies is the most
important goal. To reach this objective we need to understand the
consistency and proportion of beta cell subpopulations between
different individuals: Do we all possess the same combination of
beta cell populations and do the ratios of beta cell populations
change with disease or age? Interestingly, the study that identified
distinct beta cell subpopulations based on cell surface marker
expression determined that all four populations were present
in the islets from 17 normal individuals, but the proportions
of the subpopulations were shifted in type 2 diabetes patients
(Dorrell et al., 2016). However, there was considerable variability
between individuals in the ratio of beta cell subpopulations
that were identified by single cell mass cytometry. Furthermore,
there was no correlation of the different populations between
normal and type 2 diabetes donors; however, individual sample
populations did show correlation to body mass index, age and
diabetes (Wang et al., 2016). The different findings of these
two studies are likely not due to the different technologies
utilized, but may reflect the quality, variability and small numbers
of available human islet samples. This also highlights the
importance of additional more highly powered studies using
increased numbers of well characterized islet samples before we
can make conclusions about beta cell heterogeneity in normal and
disease states.
In addition to the concept that changes in beta cell
heterogeneity can be caused by age or disease states, it is
also worth considering the possibility that certain beta cell
populations offer protection or predisposition to diabetes.
Accordingly, the difference in the type and proportion of
each subpopulation could dictate the likelihood to developing
the disease when challenging conditions are encountered.
This could help explain why only certain individuals develop
diabetes regardless of their metabolic state. Furthermore, it
could shed light on the differential responses to treatment
that different patients have. It is possible that due to beta
cell heterogeneity, individuals will have very different disease
etiologies and develop different pathophysiologies. Ultimately,
analysis of larger samples sizes that allow for stratification of
patient islets, as well as further understanding of the intrinsic
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properties of each beta cell identity will provide us with
answers to these questions that merit significant attention. More
importantly, they will give us the necessary tools to develop
treatments that are tailored specifically for individual patients.
The existence of beta cell functional heterogeneity could
have profound implications on the development of beta cell
replacement therapies. Currently, two of the most promising
therapies for diabetes include generating alternative sources of
beta cells from stem cell populations or stimulating endogenous
beta cell proliferation. In the stem cell field, a significant amount
of effort is directed toward identifying the appropriate conditions
to obtain high quality insulin producing beta–like cells (Pagliuca
et al., 2014; Rezania et al., 2014; Yoshihara et al., 2016). However,
if different subpopulations of beta cells exist, it will be important
to identify which populations being generated in vitro, especially
if there are subpopulations of beta cells with increased replicative
and/or functional capacity. Similarly, identifying endogenous
beta cell populations with a higher proliferation propensity could
influence the therapies used to stimulate the expansion of beta
cells. Ultimately, it will be important to assess the proportions of
each subpopulation in different physiological conditions since in
order to understand the relative outcomes caused by challenging
environmental conditions, disease progression and attempted
therapies.
FUTURE PERSPECTIVES
Although the origin and extent of beta cell heterogeneity is
still unresolved, novel technologies have allowed us to gain
important clues regarding the existence of beta cell heterogeneity
and the possible environmental influences. Differences in the
proportion of beta cell subpopulations between normal and
pathological conditions are still up for debate, and whether
these subpopulations are influenced by age or external stimuli,
such as diet or body mass index, remains to be determined.
However, single cell expression studies have begun to uncover
the essential factors and pathways involved in establishing beta
cell heterogeneity and will provide the molecular tools to address
these questions. In the near future, we should be able to
elucidate the connections between molecular, morphological and
functional differences within distinct beta cell populations, in
addition to determining whether the relative beta cell populations
can be altered and by which regulatory mechanisms. Overall, the
identification and characterization of beta cell subpopulations,
and determination of their relative contribution to function and
disease will lead to more effective therapies for the prevention and
treatment of diabetes.
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